AR122036A2 - STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A - Google Patents
STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE AInfo
- Publication number
- AR122036A2 AR122036A2 ARP210101255A ARP210101255A AR122036A2 AR 122036 A2 AR122036 A2 AR 122036A2 AR P210101255 A ARP210101255 A AR P210101255A AR P210101255 A ARP210101255 A AR P210101255A AR 122036 A2 AR122036 A2 AR 122036A2
- Authority
- AR
- Argentina
- Prior art keywords
- arisulfatase
- administration
- pharmaceutical compositions
- stable pharmaceutical
- intratecal
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se refiere a la administración intratecal de enzimas lisosomales para el tratamiento eficaz de enfermedades de almacenamiento lisosomal. En algunas formas de realización, la invención proporciona formulaciones estables para la administración IT de Arilsulfatasa A. Reivindicación 1: Un envase caracterizado porque comprende una forma de dosificación unitaria de una formulación estable que comprende una proteína arilsulfatasa A (ASA) recombinante presente en una concentración que varía de aproximadamente 5 - 100 mg/ml.The present invention relates to the intrathecal administration of lysosomal enzymes for the effective treatment of lysosomal storage diseases. In some embodiments, the invention provides stable formulations for IT administration of Arylsulfatase A. Claim 1: A container characterized in that it comprises a unit dosage form of a stable formulation comprising a recombinant arylsulfatase A (ASA) protein present in a concentration ranging from about 5-100 mg/ml.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35885710P | 2010-06-25 | 2010-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR122036A2 true AR122036A2 (en) | 2022-08-03 |
Family
ID=75905105
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190102272A AR115942A2 (en) | 2010-06-25 | 2019-08-09 | STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS |
| ARP210101255A AR122036A2 (en) | 2010-06-25 | 2021-05-07 | STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A |
| ARP210103195A AR124100A2 (en) | 2010-06-25 | 2021-11-18 | PHARMACEUTICAL COMPOSITIONS FOR THE INTRATHECAL ADMINISTRATION OF LYSOSOMIC ENZYMES |
| ARP210103544A AR124399A2 (en) | 2010-06-25 | 2021-12-16 | STABLE FORMULATIONS FOR THE INTRATHECAL ADMINISTRATION OF IDURANATE-2-SULFATASE |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP190102272A AR115942A2 (en) | 2010-06-25 | 2019-08-09 | STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A AND CONTAINING CONTAINERS |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP210103195A AR124100A2 (en) | 2010-06-25 | 2021-11-18 | PHARMACEUTICAL COMPOSITIONS FOR THE INTRATHECAL ADMINISTRATION OF LYSOSOMIC ENZYMES |
| ARP210103544A AR124399A2 (en) | 2010-06-25 | 2021-12-16 | STABLE FORMULATIONS FOR THE INTRATHECAL ADMINISTRATION OF IDURANATE-2-SULFATASE |
Country Status (1)
| Country | Link |
|---|---|
| AR (4) | AR115942A2 (en) |
-
2019
- 2019-08-09 AR ARP190102272A patent/AR115942A2/en unknown
-
2021
- 2021-05-07 AR ARP210101255A patent/AR122036A2/en not_active Application Discontinuation
- 2021-11-18 AR ARP210103195A patent/AR124100A2/en unknown
- 2021-12-16 AR ARP210103544A patent/AR124399A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR124399A2 (en) | 2023-03-22 |
| AR115942A2 (en) | 2021-03-17 |
| AR124100A2 (en) | 2023-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124703T1 (en) | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONIC-2-SULFATASE | |
| CY1124910T1 (en) | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLOSULFATASE A | |
| EA201492021A1 (en) | ANTI-COMPOSITION | |
| EA201491285A1 (en) | IMPROVED COMPOSITIONS AND METHODS OF DELIVERY OF OMEPRAZOL AND ACETYLSALICYLIC ACID | |
| PE20180130A1 (en) | COMPOSITIONS AND METHODS FOR SUPPLYING THE CENTRAL NERVOUS SYSTEM OF ARYLSULFATASE A | |
| CO6700848A2 (en) | Enteric coated pancreliplase formulations, low intensity | |
| PH12017500844A1 (en) | Stable protein solution formulation containing high concentration of an anti-vegf antibody | |
| CO6680698A2 (en) | Dexmedetomidine premix formulation | |
| NZ591810A (en) | Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid | |
| GT200700034A (en) | PHARMACEUTICAL COMPOSITIONS OF ANTI-BODY ANTAGONISTS ANTI-CD40 | |
| WO2011163651A3 (en) | METHODS AND COMPOSITIONS FOR CNS DELIVERY OF β-GALACTOCEREBROSIDASE | |
| TR200900878A2 (en) | Pharmaceutical formulations combined in a single dosage form | |
| AR091530A1 (en) | PHARMACEUTICAL FORMULATION LIQUID OF AN ANTIBODY AND ACETATE | |
| GB2523707A (en) | Novel pharmaceutical formulations and their use in the treatment of periodontal disease | |
| WO2013096899A3 (en) | Stable formulations for cns delivery of arylsulfatase a | |
| MX2010004556A (en) | Pharmaceutical formulation of clavulanic acid. | |
| BR112015012497A8 (en) | pharmaceutical combinations and compositions, their uses, combined preparation, and commercial packaging | |
| UY32600A (en) | FORMULATION IN LIPIDS OF AN APOPTOSIS PROMOTER | |
| EA201390950A1 (en) | HOMOGENEOUS PHARMACEUTICAL ORAL DOSAGE FORMS CONTAINING LERKANIDIPIN AND ENALAPRIL OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS TOGETHER WITH ORGANIC ACID | |
| GT200800235A (en) | FORMULATION OF LIQUID MEDICINAL PRODUCT | |
| AR122036A2 (en) | STABLE PHARMACEUTICAL COMPOSITIONS FOR THE INTRATECAL ADMINISTRATION OF ARISULFATASE A | |
| EA201500128A1 (en) | PEDIATRIC LIQUID COMPOSITIONS FOR ORAL ADMINISTRATION CONTAINING NEPATUTANEAN | |
| TR200900880A2 (en) | Pharmaceutical compositions combined in a single dosage form. | |
| UY31212A1 (en) | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A BENZISOXAZOLIC DERIVATIVE AGENT AND A BENZODIAZEPINIC AGENT | |
| TNSN06335A1 (en) | Novel stable oral risperidone solution |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |